DHSD:LSE:LSE-WisdomTree US Equity Income UCITS ETF (USD)

ETF | Others |

Last Closing

USD 24.1425

Change

+0.31 (+1.30)%

Market Cap

N/A

Volume

479.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.07 (+0.92%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.10 (-0.54%)

USD 557.54B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.03 (-0.19%)

USD 496.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.60 (+0.84%)

USD 266.08B
0QZO:LSE 0QZO

+0.65 (+0.71%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+2.09 (+1.27%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.13 (-0.41%)

USD 200.01B
0R24:LSE Intel Corp.

+1.67 (+8.20%)

USD 196.14B

ETFs Containing DHSD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.81% 61% D- 61% D-
Dividend Return 2.57% 70% C- 84% B
Total Return 9.38% 70% C- 67% D+
Trailing 12 Months  
Capital Gain 11.14% 57% F 59% D-
Dividend Return 3.48% 77% C+ 87% B+
Total Return 14.62% 68% D+ 66% D+
Trailing 5 Years  
Capital Gain 19.50% 47% F 57% F
Dividend Return 9.17% 76% C+ 84% B
Total Return 28.68% 52% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.80% 54% F 59% D-
Dividend Return 7.27% 58% F 62% D
Total Return 1.46% 73% C 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 13.03% 53% F 70% C-
Risk Adjusted Return 55.76% 66% D+ 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike